118 related articles for article (PubMed ID: 16085197)
1. Risks and benefits of population-based genetic testing for Mendelian subsets of common diseases were examined using the example of colorectal cancer risk.
Madlensky L; McLaughlin JR; Carroll JC; Goel V; Frank JW
J Clin Epidemiol; 2005 Sep; 58(9):934-41. PubMed ID: 16085197
[TBL] [Abstract][Full Text] [Related]
2. Family-based screening for colorectal cancer: The Australian perspective.
Leggett BA
J Gastroenterol Hepatol; 2009 Oct; 24 Suppl 3():S29-32. PubMed ID: 19799695
[TBL] [Abstract][Full Text] [Related]
3. The impact of population heterogeneity on risk estimation in genetic counseling.
Liu W; Icitovic N; Shaffer ML; Chase GA
BMC Med Genet; 2004 Jun; 5():18. PubMed ID: 15228628
[TBL] [Abstract][Full Text] [Related]
4. Multiple genetic tests for susceptibility to smoking do not outperform simple family history.
Gartner CE; Barendregt JJ; Hall WD
Addiction; 2009 Jan; 104(1):118-26. PubMed ID: 19133896
[TBL] [Abstract][Full Text] [Related]
5. Prediction of Lynch syndrome in consecutive patients with colorectal cancer.
Green RC; Parfrey PS; Woods MO; Younghusband HB
J Natl Cancer Inst; 2009 Mar; 101(5):331-40. PubMed ID: 19244167
[TBL] [Abstract][Full Text] [Related]
6. Likelihood of undergoing genetic testing for cancer risk: a population-based study.
Bosompra K; Flynn BS; Ashikaga T; Rairikar CJ; Worden JK; Solomon LJ
Prev Med; 2000 Feb; 30(2):155-66. PubMed ID: 10656843
[TBL] [Abstract][Full Text] [Related]
7. [Cancer genetics: estimation of the needs of the population in France for the next ten years].
Bonaïti-Pellié C; Andrieu N; Arveux P; Bonadona V; Buecher B; Delpech M; Jolly D; Julian-Reynier C; Luporsi E; Noguès C; Nowak F; Olschwang S; Orsi F; Pujol P; Saurin JC; Sinilnikova O; Stoppa-Lyonnet D; Thépot F
Bull Cancer; 2009 Sep; 96(9):875-900. PubMed ID: 19751997
[TBL] [Abstract][Full Text] [Related]
8. Direct-to-patient BRCA1 testing: the Twoj Styl experience.
Gronwald J; Huzarski T; Byrski T; Debniak T; Metcalfe K; Narod SA; Lubiński J
Breast Cancer Res Treat; 2006 Dec; 100(3):239-45. PubMed ID: 16807675
[TBL] [Abstract][Full Text] [Related]
9. [Application of multifactor dimensionality reduction on the interactions between gene-gene, gene-environment and the risk sporadic colorectal cancer in Chinese population].
Jin MJ; Liu B; Zhang SS; Zhang YJ; Xu M; Ma XY; Yao KY; Chen K
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Jun; 29(6):535-9. PubMed ID: 19040031
[TBL] [Abstract][Full Text] [Related]
10. Health motivation and emotional vigilance in genetic testing for prostate cancer risk.
Li Y; Doukas DJ
Clin Genet; 2004 Dec; 66(6):512-6. PubMed ID: 15521978
[TBL] [Abstract][Full Text] [Related]
11. Can we identify the high-risk patients to be screened? A genetic approach.
Gammon A; Kohlmann W; Burt R
Digestion; 2007; 76(1):7-19. PubMed ID: 17947814
[TBL] [Abstract][Full Text] [Related]
12. Value of database linkage: are patients at risk of familial colorectal cancer being referred for genetic counselling and testing?
Wong C; Gibbs P; Johns J; Jones I; Faragher I; Lynch E; Macrae F; Lipton L
Intern Med J; 2008 May; 38(5):328-33. PubMed ID: 17916174
[TBL] [Abstract][Full Text] [Related]
13. Surgical prophylaxis for inheritable malignant diseases: colorectal and gastric cancer.
Benns MV; Luk T; Scoggins CR
Am Surg; 2009 Jun; 75(6):463-9. PubMed ID: 19545093
[TBL] [Abstract][Full Text] [Related]
14. Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress.
van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; Van Gool AR; Klijn JG; Tibben A
Patient Educ Couns; 2007 Jan; 65(1):58-68. PubMed ID: 16872788
[TBL] [Abstract][Full Text] [Related]
15. [Hereditary predisposition of colorectal cancer and prevalence of hereditary nonpolyposis colorectal cancer in general population of colorectal cancer patients in China].
Zhang YZ; Sheng JQ; Li SR; Wu ZT
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(42):2995-3000. PubMed ID: 16324388
[TBL] [Abstract][Full Text] [Related]
16. Perceptions of genetic testing for cancer predisposition among Ashkenazi Jewish women.
Lewis MJ; Peterson SK
Community Genet; 2007; 10(2):72-81. PubMed ID: 17380056
[TBL] [Abstract][Full Text] [Related]
17. Disparities in genetic testing: thinking outside the BRCA box.
Hall MJ; Olopade OI
J Clin Oncol; 2006 May; 24(14):2197-203. PubMed ID: 16682739
[TBL] [Abstract][Full Text] [Related]
18. Prospective results of surveillance colonoscopy in dominant familial colorectal cancer with and without Lynch syndrome.
Dove-Edwin I; de Jong AE; Adams J; Mesher D; Lipton L; Sasieni P; Vasen HF; Thomas HJ
Gastroenterology; 2006 Jun; 130(7):1995-2000. PubMed ID: 16762622
[TBL] [Abstract][Full Text] [Related]
19. Confirming a diagnosis of hereditary colorectal cancer: the impact of a Familial Bowel Cancer Registry in New Zealand.
James P; Parry S; Arnold J; Winship I
N Z Med J; 2006 Sep; 119(1242):U2168. PubMed ID: 16998569
[TBL] [Abstract][Full Text] [Related]
20. Concerns over 'shifting sands' linger as genetic testing expands.
Khamsi R
Nat Med; 2008 Jun; 14(6):589. PubMed ID: 18535560
[No Abstract] [Full Text] [Related]
[Next] [New Search]
